Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Immunogenicity and Boostability of Rabipur Rabies Vaccine
NCT02545517Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Primary completion
- Dec 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 3 trial of Human Diploid Cell Rabies Vaccine in rabies, sponsored by GSK. Started Oct 2015; status: completed.
02
Drugs
Human Diploid Cell Rabies Vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02545517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545517.